Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunoglobulin a Nephropathy (IgAN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07354932
What this trial is testing

SHR-2173 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT06786338
What this trial is testing

SGB-9768 in Patients With Complement-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)C3 GlomerulopathyIC-MPGN
Suzhou Sanegene Bio Inc. 45
Not applicableUnknownNCT00378443
What this trial is testing

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Who this might be right for
Glomerulonephritis, IGA
Peking University
Testing effectiveness (Phase 2)Study completedNCT04291781
What this trial is testing

RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 44
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Post-approval studies (Phase 4)Not Yet RecruitingNCT06528015
What this trial is testing

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAProbioticsBudesonide
Gang Xu 206
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT03373461
What this trial is testing

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 112
Testing effectiveness (Phase 2)Looking for participantsNCT07616700
What this trial is testing

Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 73
Not applicableLooking for participantsNCT04858724
What this trial is testing

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

Who this might be right for
IgA Nephropathy
Ruijin Hospital 2,000
Not applicableNot Yet RecruitingNCT07746453
What this trial is testing

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Primary Membranous Nephropathy
Guangdong Provincial People's Hospital 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06982040
What this trial is testing

Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Nanjing Chia-tai Tianqing Pharmaceutical 80
Large-scale testing (Phase 3)Study completedNCT03643965
What this trial is testing

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 365
Testing effectiveness (Phase 2)Study completedNCT07634744
What this trial is testing

A Phase IIa Study in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
S-INFINITY Pharmaceuticals Co., Ltd 25
Testing effectiveness (Phase 2)Study completedNCT04014335
What this trial is testing

Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Ionis Pharmaceuticals, Inc. 23
Not applicableLooking for participantsNCT07585981
What this trial is testing

Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.

Who this might be right for
IgA Glomerulonephritis
Chinese PLA General Hospital 30
Not applicableStudy completedNCT06589752
What this trial is testing

Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

Who this might be right for
Primary IgA Nephropathy
Ruijin Hospital 200
Very early researchLooking for participantsNCT07498673
What this trial is testing

YKST02 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Next Page